HS Heading 3002
Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
12 tariff lines in this heading, within chapter 30 (Pharmaceutical products). Click any HS code for the full breakdown and a duty calculation.
| HS Code | Description | CD | SD | VAT | AIT | RD | AT | TTI |
|---|---|---|---|---|---|---|---|---|
| 30021200 | Antisera and other blood fractions | 0 | 0 | 0 | 5 | 0 | 0 | 5% |
| 30021300 | Immunological products, unmixed, not put up in measured doses or in forms or packings | 0 | 0 | 0 | 5 | 0 | 0 | 5% |
| 30021400 | Immunological products, mixed, not put up in measured doses or in forms or packings | 0 | 0 | 0 | 5 | 0 | 0 | 5% |
| 30021500 | Immunological products, put up in measured doses or in forms or packings for retail | 0 | 0 | 0 | 5 | 0 | 0 | 5% |
| 30024100 | Vaccines for human medicine | 0 | 0 | 15 | 2 | 0 | 7.5 | 24.5% |
| 30024200 | Vaccines for veterinary medicine | 0 | 0 | 0 | 5 | 0 | 7.5 | 12.5% |
| 30024900 | Vaccines, NES | 0 | 0 | 15 | 5 | 0 | 7.5 | 27.5% |
| 30025100 | Cell cultures, whether or not modified , Cell therapy products | 0 | 0 | 15 | 5 | 0 | 7.5 | 27.5% |
| 30025900 | Cell cultures, whether or not modified, EXC.Cell therapy products | 0 | 0 | 15 | 5 | 0 | 7.5 | 27.5% |
| 30029010 | Saxitoxin | 0 | 0 | 0 | 5 | 0 | 0 | 5% |
| 30029020 | Ricin | 0 | 0 | 0 | 5 | 0 | 0 | 5% |
| 30029090 | Other | 0 | 0 | 0 | 5 | 0 | 0 | 5% |
Recorded imports
Between December 2025 and May 2026, NBR recorded commercial imports worth BDT 17,833,277,123 (475,163 kg) under this heading, across 9 of its 12 tariff lines. The remaining 3 recorded no commercial import in that window.
| Month | Lines with imports | Net weight | Assessable value |
|---|---|---|---|
| December 2025 | 6 | 75,702 kg | BDT 2,770,783,893 |
| January 2026 | 6 | 93,449 kg | BDT 5,184,745,368 |
| February 2026 | 8 | 31,326 kg | BDT 1,260,830,899 |
| March 2026 | 8 | 57,207 kg | BDT 1,682,920,673 |
| April 2026 | 7 | 73,532 kg | BDT 1,896,294,908 |
| May 2026 | 7 | 143,947 kg | BDT 5,037,701,382 |
The largest lines by assessable value in May 2026:
- 30024100 — Vaccines for human medicine — BDT 4,174,428,662
- 30024200 — Vaccines for veterinary medicine — BDT 545,816,141
- 30021200 — Antisera and other blood fractions — BDT 136,761,627
- 30021500 — Immunological products, put up in measured doses or in forms or packings for retail — BDT 89,566,964
- 30029090 — Other — BDT 82,591,891
Bonded imports. A further BDT 139,494 (46 kg) entered under the bonded-warehouse regime over the same months — duty-free inputs imported against an undertaking to re-export them. That is 0.0% of the total value imported under this heading.
Import figures: NBR Import Statements (IM-4 commercial, IM-7 bonded), December 2025 – May 2026. Assessable value is the customs value on which duty is charged, not the retail or invoice price.